Publication:
Micronization of dihydroartemisinin by rapid expansion of supercritical solutions

dc.contributor.authorJiraporn Chingunpitaken_US
dc.contributor.authorSatit Puttipipatkhachornen_US
dc.contributor.authorYuichi Tozukaen_US
dc.contributor.authorKunikazu Moribeen_US
dc.contributor.authorKeiji Yamamotoen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherGifu Pharmaceutical Universityen_US
dc.contributor.otherChiba Universityen_US
dc.date.accessioned2018-07-12T02:18:28Z
dc.date.available2018-07-12T02:18:28Z
dc.date.issued2008-06-01en_US
dc.description.abstractThe purpose of this study was to prepare fine particles of antimalarial drug dihydroartemisinin (DHA) by rapid expansion of supercritical solutions (RESS) using carbon dioxide as supercritical fluid. The mechanical grinding by jet mill and additional vibration rod mill also was performed as a comparative method. In the RESS process, drug particles were prepared by varying processing conditions, including extraction condition, pre-expansion condition, nozzle diameter, nozzle temperature, and collecting distance. Particle size and morphology and physicochemical characteristics of the drug particles were investigated. The RESS process could produce the smaller drug particles (about 1-2 μm) when compared to mechanical grinding method (about 7 μm). All RESS processing parameters had an effect on size and morphology of drug particles. The particle size of drug was related to the solubility of drug in supercritical CO2 at each processing condition. The fine particles of DHA (about 1 μm) with narrow size distribution could be obtained at extraction pressure of 18 MPa and extraction temperature of 32°C, which was closed to the critical temperature of supercritical CO2 whereas broad size distribution was obtained at extraction temperature of 60°C. Powder X-ray diffraction study indicated that the RESS-processed particles were in crystalline form. The results revealed that RESS process is applicable for micronization of DHA. Copyright © Informa Healthcare USA, Inc.en_US
dc.identifier.citationDrug Development and Industrial Pharmacy. Vol.34, No.6 (2008), 609-617en_US
dc.identifier.doi10.1080/03639040701833682en_US
dc.identifier.issn15205762en_US
dc.identifier.issn03639045en_US
dc.identifier.other2-s2.0-45849151126en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/18914
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=45849151126&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleMicronization of dihydroartemisinin by rapid expansion of supercritical solutionsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=45849151126&origin=inwarden_US

Files

Collections